source
- Celcuity's Revtorpyk receives FDA approval, but launch delay pushes stock lowerThe FDA announced approval of Celcuity’s oncology candidate Revtorpyk on Tuesday, marking the company’s first cancer drug clearance. Analysts had broadly expected the approval and had priced the s…
- Medicare proposal would boost doctor pay for smoking and alcohol counseling by 19%A proposed change to Medicare’s physician fee schedule would increase reimbursement for doctors who provide counseling on tobacco cessation and alcohol or substance misuse. The proposal adds a 19%…